Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
about
Inhaled corticosteroids for subacute and chronic cough in adultsLong-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthmaUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsDosing Recommendations for Concomitant Medications During 3D Anti-HCV TherapyLoss of asthma control in pediatric patients after discontinuation of long-acting Beta-agonistsThe effects of inhaled corticosteroids on growth in children.Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549)Inhalational Steroids and Iatrogenic Cushing's SyndromePharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study.Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.The effect of inhaled corticosteroids on hypothalamic-pituitary-adrenal axisIn vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.Inhaled corticosteroids in lung diseases.Management of asthma in the elderly patient.Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.Bioavailability of inhaled fluticasone propionate via chambers/masks in young children.Comparison of inhaled corticosteroids: an update.The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.Effects of Inhalable Microparticles of Seonpyejeongcheon-Tang in an Asthma Mouse Model: - Effects of Microparticles of SJT.Ciclesonide and the treatment of asthma.Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.Treating the small airways.A review of mometasone furoate / formoterol in the treatment of asthma.Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma.Inhaled corticosteroids for asthma: on-demand or continuous use.Flunisolide for the treatment of asthma.Safety considerations of inhaled corticosteroids in the elderly.Inhaled corticosteroids and HPA axis suppression: how important is it and how should it be managed?Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool.Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma.The influence of sodium hyaluronate, L-leucine and sodium taurocholate on the nebulization of aqueous betamethasone-17-valerate suspensions.Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects.Evaluation of Proper Usage of Glucocorticosteroid Inhalers and Their Adverse Effects in Asthmatic PatientsSystemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.
P2860
Q24200175-B0F2D174-89CB-4759-BA28-D87734027342Q24634033-CD563181-6A3C-4DAA-BDA4-B64FD1B5D4CAQ28066822-F5E4DCE7-570C-496C-8047-6EADE22579AAQ28080752-9E6E7800-3CBE-40D4-A5C5-D9E17855D3F0Q28388214-0C240C32-7E34-4692-B57D-BA73BD52BC02Q30419000-1A191412-5B8C-4778-B842-0DA2B714F9D3Q33300580-D8007081-ECC5-47E8-9AF4-DA4956BD8292Q35056151-B4EBBC34-05CD-44A4-82A9-12F522BFE103Q35113606-95D7B658-355B-4228-9F84-1798F1898B09Q35216003-4DB8401F-7735-4F6E-9145-25C77AB27A1BQ35225926-5795A8ED-65D2-4749-8442-2FD029DDAA42Q35994264-E2401AAD-603B-44B2-BE36-782069963050Q36020998-0441E9EE-251D-4693-BA6B-2C89E5E76976Q36128735-7CCAAA77-F30C-4CD8-ADC3-37B4ECFFA039Q36336028-635D7DCA-8B27-4CA7-B91E-1B372316FC14Q36999789-B8BC6964-30BF-4286-80F0-3A10345495DEQ37027409-DCDD0864-C5EB-49F6-9E19-D52610400D6FQ37062092-A87B9967-FE47-47B7-9BFB-E11FF8EABCA4Q37335221-8EC13282-745E-4E90-B211-65F1AEE8AD47Q37406595-891C1CFD-E760-4759-BB8E-7ACB13425F75Q37428235-FC9C3CB6-3D3A-49DA-8F09-99565BB131BCQ37585203-A751CF37-FD89-46D6-ADB4-68528382650FQ37681579-CA785812-A3F5-45DC-A3C3-78CAEC85EBA8Q37810240-21EAAB1A-BA7A-430D-AC9A-48BB62FA33DCQ38060087-7260E87C-36A2-4604-8585-EAED67936B4DQ38077842-97B65E4C-D9E4-4FCE-BC70-201340C21D1FQ38130512-E8BEDA55-F227-4032-A6C4-9368B4314BF4Q38154624-38690AB0-9E33-45E6-AE27-A7D6DE8F2187Q38203322-0AA60CB3-AFD4-4A82-9348-8A49017476B6Q38248458-584321BB-F2A9-42C9-8AF5-64DE34EB5A14Q38796254-A756F8BC-F026-4A58-B967-B83696ACEB39Q38840402-61D8D46C-863A-4E8D-90FE-B885D50FEA9BQ38851423-D139652F-677E-487C-8186-C0DEAF24B595Q39678636-0B16D730-E272-4FF1-9E18-58088D31E6BCQ40109458-4D29A26A-3E30-4A5D-80F3-ADCDB6977195Q41471780-58D550EF-ACCC-40E5-BAC7-EB952C573FB8Q41553354-90C68F97-9F3E-48F9-AF8C-E3B10ECD698FQ42428123-72A59B76-C349-4EEF-874E-DDAD8C2A50DBQ42629467-131EBC56-2099-4B87-84C1-FF93331CDFBBQ42854436-88C91375-F28B-4129-85D3-3B25D19C34E0
P2860
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@ast
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@en
type
label
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@ast
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@en
prefLabel
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@ast
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@en
P2093
P1476
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
@en
P2093
P304
P356
10.1183/09031936.00074905
P577
2006-11-01T00:00:00Z